TestHBankH-HPharmacology:H AHPatient-CenteredHNursingHProcessHApproachH(9thHEdition,H2017)
PHARMACOLOGYH9THHEDITIONHMCCUISTIONHTESTHBANK
ThisHisHaHsetHofHquestionsHtoHanswerHtheHquestionsHofHtheHtextbookH"Pharmacology:HAHPatient-
CenteredHNursingHProcessHApproachH9thHEdition"HitHhelpsHyouHtoHbetterHunderstandHtheHbookHcorr
ectly.
GetHtheHrightHdosageHofHpharmacologyHcontentHtoHsucceedHonHtheHNCLEXHandHasHaHprofessionalHnur
seHwithH"Pharmacology:HAHPatient-
CenteredHNursingHProcessHApproach,H9thHEdition".HUsingHaHstreamlinedHprototypeHapproachHandHanH
emphasisHonHnursingHcare,HthisHtextHmakesHitHeasyHforHtoday’sHnursingHstudentsHtoHbetterHunderstan
dHtheHcomplicatedHsubjectHofHpharmacology.HTheHbook’sHdetailedHchapterHonHdosageHcalculation,HtheH
nursingHprocessHframeworkHforHdrugHtherapy,HstrongHQSENHfocus,HandHsummariesHofHprototypeHdru
gsHhelpHdeliverHtheHperfect.
1
,TestHBankH-HPharmacology:HAHPatient-CenteredHNursingHProcessHApproachH(9thHEdition,H2017)
PHARMACOLOGYH9THHEDITIONHMCCUISTIONHTESTHBANK
Table of Contents
H H
TableHofHContents ChapterH28:HPeptides,HAntimalarial,Hand
ChapterH01:HDrugHDevelopmentHan Anthelmintic
dHEthicalHConsiderations ChapterH29:HHIV-HandHAIDS-
ChapterH02:HPharmacokinetics,H RelatedHDrugs
Pharmacodynamics,HandHPhar ChapterH30:HTransplantHDrugs
macogenetics ChapterH31:HVaccinesHChapt
H
ChapterH03:HCulturalHConsiderations erH32:HAnticancerHDrugs
ChapterH04:HComplementaryHandHAl
H ChapterH33:HTargetedHTherapiesHtoHTrea
ternativeHTherapies tHCancer
ChapterH05:HPediatricHConsideration ChapterH34:HBiologicHResponse
sHChapterH06:HGeriatricHConsideration Modifiers
H
sHChapterH07:HDrugsHinHSubstanceHU ChapterH35:HUpperHRespiratory
seHDisorder Disorders
H
ChapterH08:HTheHNursingHProcessHan ChapterH36:HLowerHRespiratory
dHPatient-CenteredHCare Disorders
H
ChapterH09:HSafetyHandHQualityH ChapterH37:HCardiacHGlycosides,HA
ChapterH10:HDrugHAdministration ntianginals,HandHAntidysrhythmicsH
ChapterH11:HDrugHCalculationsH
H ChapterH38:HDiuretics
ChapterH12:HFluidHVolumeHandHE ChapterH39:HAntihypertensive
lectrolytes ChapterH40:HAnticoagulants,HAntipla
ChapterH13:HVitaminHandHMinera telets,HandHThrombolyticsHChapterH4
lHReplacement 1:HAntihyperlipidemicsHandHPeriphera
ChapterH14:HNutritionalHSupportHCha lHVasodilators
pterH15:HAdrenergicHAgonistsHandHAnt ChapterH42:HGastrointestinalHTract
agonists Disorders
H
ChapterH16:HCholinergicHAgonistsHan ChapterH43:HAntiulcerHDrugsHChapt
dHAntagonists erH44:HEyeHandHEarHDisordersHChap
ChapterH17:HStimulants terH45:HDermatologicHDisordersHCha
ChapterH18:HDepressantsHCha pterH46:HPituitary,HThyroid,HParathyr
pterH19:HAntiseizureHDrugs oid,HandHAdrenalHDisordersHChapter
ChapterH20:HDrugsHforHParkinsonismHan H47:HAntidiabetics
dHAlzheimer'sHDisease ChapterH48:HUrinaryHDisordersHCha
ChapterH21:HDrugsHforHNeuromuscula pterH49:HPregnancyHandHPretermHLab
rHDisordersHandHMuscleHSpasmsHChap or
terH22:HAntipsychoticsHandHAnxiolytics ChapterH50:HLabor,HDelivery,Han
ChapterH23:HAntidepressantsHandHMoo dHPostpartum
dHStabilizers ChapterH51:HNeonatalHandHNewbor
ChapterH24:HAntiinflammatories nHChapterH52:HWomen'sHReproducti
ChapterH25:HAnalgesics veHHealth
ChapterH26:HAntibacterials ChapterH53:HMen'sHReproductiveHHealt
ChapterH27:HAntituberculars,HAntifungals, hHChapterH54:HSexuallyHTransmittedHInfe
andHAntivirals
H ctions
ChapterH55:HAdultHandHPediatric
2
,TestHBankH-HPharmacology:HAHPatient-CenteredHNursingHProcessHApproachH(9thHEdition,H2017)
PHARMACOLOGYH9THHEDITIONHMCCUISTIONHTESTHBANK
EmergencyHDrugs
3
, TestHBankH-HPharmacology:HAHPatient-CenteredHNursingHProcessHApproachH(9thHEdition,H2017)
PHARMACOLOGYH9THHEDITIONHMCCUISTIONHTESTHBANK
Chapter 01: Drug Development and Ethical Considerations
H H H H H H
MULTIPLEHCHOICE
1. TheHnurseHisHpreparingHtoHadministerHaHscheduleHIIHinjectableHdrugHandHisHdrawingHupHhalfH
ofHtheHcontentsHofHaHSingle-useHvial.HWhichHnursingHactionHisHcorrect?
a. AskHanotherHnurseHtoHobserveHandHcosignHwastingHtheHremainingHdrugHfromHtheHvial.
b. KeepHtheHremainingHamountHinHtheHpatient’sHdrawerHtoHgiveHatHtheHnextHdose.
c. RecordHtheHamountHunusedHinHtheHpatient’sHmedicationHrecord.
d. DisposeHofHtheHvialHwithHtheHremainingHdrugHintoHaHlockedHcollectionHbo
x.HANS:HA
ScheduleHIIHdrugsHareHcontrolledHsubstances,HandHallHmustHbeHaccountedHfor.HWhenHwasting
HaHportionHofHaHdrug,HanotherHnurseHshouldHobserveHandHcosignHthatHaHdrugHwasHwasted.
DIF:HCOGNITIVEHLEVEL:HApplyingH(Application)
HTOP:HNURSINGHPROCESS:HNursingHInterventio
n
MSC:HNCLEX:HPhysiologicalHIntegrity:HPharmacologicalHandHParenteralHTherapies
2. AHpatientHisHprescribedHaHmedicationHandHasksHtheHnurseHifHtheHdrugHisHavailableHinHaHgener
icHform.HTheHnurseHunderstandsHthatHaHgenericHmedicationHwillHhaveHaHnameHthat
a. isHaHregisteredHtrademark.
b. isHalwaysHcapitalized.
c. describesHtheHdrugsHchemicalHstructure.
d. isHnon-
proprietary.HANS:HD
TheHgenericHnameHisHtheHofficial,Hnon-
proprietaryHnameHforHaHdrug.HTheHbrandHnameHisHtheHtrademarkHnameHandHisHalwaysHcapitalized.
HTheHchemicalHnameHdescribesHtheHchemicalHstructureH ofHtheHdrug.
DIF:HCOGNITIVEHLEVEL:HUnderstandingH(Comprehension
)HTOP:HNURSINGHPROCESS:HN/A
MSC:HNCLEX:HPhysiologicalHIntegrity:HPharmacologicalHandHParenteralHTherapies
3. AHpatientHreceivesHaHprescriptionHonHwhichHtheHproviderHhasHnotedHthatHaHgenericHmedicati
onHmayHbeHgiven.TheHpatientHasksHtheHnurseHwhatHthisHmeans.HWhatHwillHtheHnurseHtellHtheHpa
tientHaboutHgenericHdrugs?
a. TheyHcontainHtheHsameHinertHingredientsHasHbrand-nameHdrugs.
b. TheyHhaveHchemicalHstructuresHthatHareHidenticalHtoHproprietaryHdrugs.
c. TheyHtendHtoHbeHlessHexpensiveHthanHbrand-nameHdrugs.
d. TheyHundergoHextensiveHtestingHbeforeHtheyHareHmarkete
d.HANS:HC
GenericHdrugsHareHapprovedHbyHtheHFDAHifHtheyHareHprovedHtoHbeHbioequivalentHtoHtheHbrand-
HnameHdrug.HTheyHtendHtoHbeHlessHexpensiveHbecauseHmanufacturersHofHtheseHdrugsHdoHnotHha
veHtoHdoHtheHextensiveHtestingHrequiredHofHbrand-
nameHdrugsHbeforeHmarketing.HTheyHareHnotHidenticalHtoHbrand-
nameHdrugsHandHoftenHhaveHdifferentHinertHingredients.
DIF:HCOGNITIVEHLEVEL:HApplyingH(Application)
TOP:HNURSINGHPROCESS:HNursingHIntervention:HPatientHTeachingH
MSC:HNCLEX:HManagementHofHClientHCare
4. TheHnurseHreviewsHinformationHaboutHaHdrugHandHnotesHtheHinitialsHUSPHafterHtheHdrugsHoffici
alHname.HTheHnurseHunderstandsHthatHthisHdesignationHindicatesHtheHdrug
a. isHaHcontrolledHsubstance.
PHARMACOLOGYH9THHEDITIONHMCCUISTIONHTESTHBANK
ThisHisHaHsetHofHquestionsHtoHanswerHtheHquestionsHofHtheHtextbookH"Pharmacology:HAHPatient-
CenteredHNursingHProcessHApproachH9thHEdition"HitHhelpsHyouHtoHbetterHunderstandHtheHbookHcorr
ectly.
GetHtheHrightHdosageHofHpharmacologyHcontentHtoHsucceedHonHtheHNCLEXHandHasHaHprofessionalHnur
seHwithH"Pharmacology:HAHPatient-
CenteredHNursingHProcessHApproach,H9thHEdition".HUsingHaHstreamlinedHprototypeHapproachHandHanH
emphasisHonHnursingHcare,HthisHtextHmakesHitHeasyHforHtoday’sHnursingHstudentsHtoHbetterHunderstan
dHtheHcomplicatedHsubjectHofHpharmacology.HTheHbook’sHdetailedHchapterHonHdosageHcalculation,HtheH
nursingHprocessHframeworkHforHdrugHtherapy,HstrongHQSENHfocus,HandHsummariesHofHprototypeHdru
gsHhelpHdeliverHtheHperfect.
1
,TestHBankH-HPharmacology:HAHPatient-CenteredHNursingHProcessHApproachH(9thHEdition,H2017)
PHARMACOLOGYH9THHEDITIONHMCCUISTIONHTESTHBANK
Table of Contents
H H
TableHofHContents ChapterH28:HPeptides,HAntimalarial,Hand
ChapterH01:HDrugHDevelopmentHan Anthelmintic
dHEthicalHConsiderations ChapterH29:HHIV-HandHAIDS-
ChapterH02:HPharmacokinetics,H RelatedHDrugs
Pharmacodynamics,HandHPhar ChapterH30:HTransplantHDrugs
macogenetics ChapterH31:HVaccinesHChapt
H
ChapterH03:HCulturalHConsiderations erH32:HAnticancerHDrugs
ChapterH04:HComplementaryHandHAl
H ChapterH33:HTargetedHTherapiesHtoHTrea
ternativeHTherapies tHCancer
ChapterH05:HPediatricHConsideration ChapterH34:HBiologicHResponse
sHChapterH06:HGeriatricHConsideration Modifiers
H
sHChapterH07:HDrugsHinHSubstanceHU ChapterH35:HUpperHRespiratory
seHDisorder Disorders
H
ChapterH08:HTheHNursingHProcessHan ChapterH36:HLowerHRespiratory
dHPatient-CenteredHCare Disorders
H
ChapterH09:HSafetyHandHQualityH ChapterH37:HCardiacHGlycosides,HA
ChapterH10:HDrugHAdministration ntianginals,HandHAntidysrhythmicsH
ChapterH11:HDrugHCalculationsH
H ChapterH38:HDiuretics
ChapterH12:HFluidHVolumeHandHE ChapterH39:HAntihypertensive
lectrolytes ChapterH40:HAnticoagulants,HAntipla
ChapterH13:HVitaminHandHMinera telets,HandHThrombolyticsHChapterH4
lHReplacement 1:HAntihyperlipidemicsHandHPeriphera
ChapterH14:HNutritionalHSupportHCha lHVasodilators
pterH15:HAdrenergicHAgonistsHandHAnt ChapterH42:HGastrointestinalHTract
agonists Disorders
H
ChapterH16:HCholinergicHAgonistsHan ChapterH43:HAntiulcerHDrugsHChapt
dHAntagonists erH44:HEyeHandHEarHDisordersHChap
ChapterH17:HStimulants terH45:HDermatologicHDisordersHCha
ChapterH18:HDepressantsHCha pterH46:HPituitary,HThyroid,HParathyr
pterH19:HAntiseizureHDrugs oid,HandHAdrenalHDisordersHChapter
ChapterH20:HDrugsHforHParkinsonismHan H47:HAntidiabetics
dHAlzheimer'sHDisease ChapterH48:HUrinaryHDisordersHCha
ChapterH21:HDrugsHforHNeuromuscula pterH49:HPregnancyHandHPretermHLab
rHDisordersHandHMuscleHSpasmsHChap or
terH22:HAntipsychoticsHandHAnxiolytics ChapterH50:HLabor,HDelivery,Han
ChapterH23:HAntidepressantsHandHMoo dHPostpartum
dHStabilizers ChapterH51:HNeonatalHandHNewbor
ChapterH24:HAntiinflammatories nHChapterH52:HWomen'sHReproducti
ChapterH25:HAnalgesics veHHealth
ChapterH26:HAntibacterials ChapterH53:HMen'sHReproductiveHHealt
ChapterH27:HAntituberculars,HAntifungals, hHChapterH54:HSexuallyHTransmittedHInfe
andHAntivirals
H ctions
ChapterH55:HAdultHandHPediatric
2
,TestHBankH-HPharmacology:HAHPatient-CenteredHNursingHProcessHApproachH(9thHEdition,H2017)
PHARMACOLOGYH9THHEDITIONHMCCUISTIONHTESTHBANK
EmergencyHDrugs
3
, TestHBankH-HPharmacology:HAHPatient-CenteredHNursingHProcessHApproachH(9thHEdition,H2017)
PHARMACOLOGYH9THHEDITIONHMCCUISTIONHTESTHBANK
Chapter 01: Drug Development and Ethical Considerations
H H H H H H
MULTIPLEHCHOICE
1. TheHnurseHisHpreparingHtoHadministerHaHscheduleHIIHinjectableHdrugHandHisHdrawingHupHhalfH
ofHtheHcontentsHofHaHSingle-useHvial.HWhichHnursingHactionHisHcorrect?
a. AskHanotherHnurseHtoHobserveHandHcosignHwastingHtheHremainingHdrugHfromHtheHvial.
b. KeepHtheHremainingHamountHinHtheHpatient’sHdrawerHtoHgiveHatHtheHnextHdose.
c. RecordHtheHamountHunusedHinHtheHpatient’sHmedicationHrecord.
d. DisposeHofHtheHvialHwithHtheHremainingHdrugHintoHaHlockedHcollectionHbo
x.HANS:HA
ScheduleHIIHdrugsHareHcontrolledHsubstances,HandHallHmustHbeHaccountedHfor.HWhenHwasting
HaHportionHofHaHdrug,HanotherHnurseHshouldHobserveHandHcosignHthatHaHdrugHwasHwasted.
DIF:HCOGNITIVEHLEVEL:HApplyingH(Application)
HTOP:HNURSINGHPROCESS:HNursingHInterventio
n
MSC:HNCLEX:HPhysiologicalHIntegrity:HPharmacologicalHandHParenteralHTherapies
2. AHpatientHisHprescribedHaHmedicationHandHasksHtheHnurseHifHtheHdrugHisHavailableHinHaHgener
icHform.HTheHnurseHunderstandsHthatHaHgenericHmedicationHwillHhaveHaHnameHthat
a. isHaHregisteredHtrademark.
b. isHalwaysHcapitalized.
c. describesHtheHdrugsHchemicalHstructure.
d. isHnon-
proprietary.HANS:HD
TheHgenericHnameHisHtheHofficial,Hnon-
proprietaryHnameHforHaHdrug.HTheHbrandHnameHisHtheHtrademarkHnameHandHisHalwaysHcapitalized.
HTheHchemicalHnameHdescribesHtheHchemicalHstructureH ofHtheHdrug.
DIF:HCOGNITIVEHLEVEL:HUnderstandingH(Comprehension
)HTOP:HNURSINGHPROCESS:HN/A
MSC:HNCLEX:HPhysiologicalHIntegrity:HPharmacologicalHandHParenteralHTherapies
3. AHpatientHreceivesHaHprescriptionHonHwhichHtheHproviderHhasHnotedHthatHaHgenericHmedicati
onHmayHbeHgiven.TheHpatientHasksHtheHnurseHwhatHthisHmeans.HWhatHwillHtheHnurseHtellHtheHpa
tientHaboutHgenericHdrugs?
a. TheyHcontainHtheHsameHinertHingredientsHasHbrand-nameHdrugs.
b. TheyHhaveHchemicalHstructuresHthatHareHidenticalHtoHproprietaryHdrugs.
c. TheyHtendHtoHbeHlessHexpensiveHthanHbrand-nameHdrugs.
d. TheyHundergoHextensiveHtestingHbeforeHtheyHareHmarkete
d.HANS:HC
GenericHdrugsHareHapprovedHbyHtheHFDAHifHtheyHareHprovedHtoHbeHbioequivalentHtoHtheHbrand-
HnameHdrug.HTheyHtendHtoHbeHlessHexpensiveHbecauseHmanufacturersHofHtheseHdrugsHdoHnotHha
veHtoHdoHtheHextensiveHtestingHrequiredHofHbrand-
nameHdrugsHbeforeHmarketing.HTheyHareHnotHidenticalHtoHbrand-
nameHdrugsHandHoftenHhaveHdifferentHinertHingredients.
DIF:HCOGNITIVEHLEVEL:HApplyingH(Application)
TOP:HNURSINGHPROCESS:HNursingHIntervention:HPatientHTeachingH
MSC:HNCLEX:HManagementHofHClientHCare
4. TheHnurseHreviewsHinformationHaboutHaHdrugHandHnotesHtheHinitialsHUSPHafterHtheHdrugsHoffici
alHname.HTheHnurseHunderstandsHthatHthisHdesignationHindicatesHtheHdrug
a. isHaHcontrolledHsubstance.
